Mangaceuticals Inc. (MGRX)
NASDAQ (CM) NASDAQ (CM) Primary Summary
Why Is Mangoceuticals (MGRX) Stock Up 130% Today?
Mangoceuticals (NASDAQ: MGRX ) stock climbed up a staggering 130% at one point today after the company announced that its new oral formulations of its Semaglutide (“Slim”) and Tirzepatide (“Trim”) treatments have proven notably effective in clinical trials. What does this mean for MGRX stock?
Mangaceuticals Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| DP Drew Phillips Fortitude Family Office LLC | 378 | $280 | $139.86 | -$140.14 | -50.05% |
Mangaceuticals Inc. (MGRX) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Mangaceuticals Inc. ever had a stock split?
Mangaceuticals Inc. Profile
| Consumer Staples Distribution & Retail Industry | Consumer Staples Sector | Jacob D. Cohen CEO | NASDAQ (CM) Exchange | 56270V106 CUSIP |
| US Country | 3 Employees | - Last Dividend | 16 Oct 2024 Last Split | 21 Mar 2023 IPO Date |
Overview
Mangoceuticals, Inc. is an innovative telemedicine company that operates within the United States, focusing on the development, marketing, and selling of men's wellness products and services. The company leverages a digital platform to offer solutions, primarily for erectile dysfunction (ED) and hair loss. Incorporated in 2021 with its headquarters in Dallas, Texas, Mangoceuticals serves as a subsidiary of Cohen Enterprises, Inc. Through strategic marketing agreements and an online presence, the company aims to cater to the needs of men seeking discreet and accessible treatment options.
Products and Services
- Erectile Dysfunction (ED) Products:
- Hair Loss Products:
- KYZATREX - Oral Testosterone Replacement Therapy Product:
Under the Mango brand, Mangoceuticals, Inc. offers a range of products designed to address erectile dysfunction. These products are developed with the aim of providing effective and convenient treatment options for men facing ED challenges. They are available for purchase online, enhancing accessibility and privacy for users.
The Grow brand encompasses a variety of hair loss solutions offered by Mangoceuticals, Inc. These products are targeted towards men experiencing hair loss, providing them with a line of treatments aimed at promoting hair growth and preventing further hair loss. Like the ED products, these are also sold online, making it easy for customers to access them discreetly.
In collaboration with Marius Pharmaceuticals, LLC, Mangoceuticals markets and sells KYZATREX through the PRIME program. KYZATREX is an oral testosterone replacement therapy intended for men with a deficiency or absence of endogenous testosterone. This partnership broadens the range of men's wellness products offered by Mangoceuticals, catering to a wider set of needs within the realm of men's health.
